Clinical Research Directory
Browse clinical research sites, groups, and studies.
The Vanderbilt Atrial Fibrillation Ablation Registry
Sponsor: Vanderbilt University
Summary
The Vanderbilt Atrial Fibrillation Ablation registry (VAFAR) is a prospective clinical and genetic biorepository that systematically enrolls patients undergoing atrial fibrillation (AF) ablation. The registry was started in 2011 and has greater than 1000 AF ablation records with stored blood and DNA samples. The goals of VAFAR are to: 1) identify clinical, genetic, and serological predictors of response to AF ablation in order to improve patient selection, and 2) to provide a resource for translational research investigating the electrophysiologic mechanisms of AF pathogenesis.
Key Details
Gender
All
Age Range
18 Years - Any
Study Type
OBSERVATIONAL
Enrollment
2478
Start Date
2011-10
Completion Date
2028-10
Last Updated
2026-03-25
Healthy Volunteers
No
Conditions
Locations (1)
Vanderbilt University Medical Center
Nashville, Tennessee, United States